CXS chemgenex pharmaceuticals ltd

the big kahuna

  1. 724 Posts.
    lightbulb Created with Sketch. 29
    from todays announcement on presentations:

    ChemGenex will also present combination data for Omapro during the poster session entitled: Chronic
    Myeloid Leukemia - Therapy on Sunday, December 6th from 6:00 to 8:00 p.m. Central Time on Poster
    Board II-170. This phase 2 trial was designed to study the “Combination of Omacetaxine and Imatinib
    in the Treatment of Patients with CML in Advanced Stages or After Failure to Imatinib”.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.